A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas
Laurien L. van de Weijer(University of Plymouth), C. Oliver Hanemann(University of Plymouth)
Cited by 15
Related Papers
Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2
|Neuro-Oncology|2011|54
GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma
|EBioMedicine|2020|41